Furthermore, loss of Smad3 was found to promote abdominal aortic aneurysm formation in mouse models of inflammatory abdominal aortic aneurysm [50]; shSmad3 gene therapy might have side effect: aneurysm. This evidence concerns the gene SMAD3 and aneurysm.